Smart for Life to Hold Shareholder Meeting on March 15, 2023
Shareholder Meeting Follows the Company’s Successful Hearing with the Nasdaq Hearings PanelMIAMI, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Smart for...
Nutrition
First Wave BioPharma Chairman and CEO Issues Letter to Stockholders
BOCA RATON, Fla., Feb. 13, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave BioPharma” or the “Company”),...
Male Plus Is a Libido Enhancer Designed by One of the Health and Wellness Elite
Brand Founder Tim Torfs Has Nearly Two Decades of Experience Ranging Across the Health and Wellness IndustryFort Lauderdale, FL, Feb....
Male Plus Arouses Attention from Those With ED
Erections Can Be Hard to Maintain. Male Plus Delivers Natural Support.Fort Lauderdale, FL, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Erectile...
Bon Natural Life Limited Announces FY2022 Earnings Release Date and Webcast
Earnings to be released before market opens on Friday, February 10, 2023XIAN, China, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Bon...
QHSLab, Inc. Reiterates its 2022 Projection of a $7.5 Billion Addressable Market for its Integrated Service Program (ISP) Digital Health Solution Designed For Primary Care
QHSLab reports that commercialization and the path to profitability is in clear sight, which is an unfamiliar acknowledgment for investors...
BioCorRx to Present at Sequire Biotechnology Conference on February 2nd
Presentation on Thursday, February 2, 2023 at 2:00 PM ET ANAHEIM, CA, Jan. 27, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc....
Orchestra BioMed Debuts as Nasdaq-Traded Company with Lead Programs Targeting Hypertension and Artery Disease and Novel Partnership-Enabled Business Model
Business combination with Health Sciences Acquisitions Corporation 2, a special purpose acquisition company sponsored by an affiliate of RTW Investments,...
Novozymes delivers historically strong full-year results
Novozymes is delivering strong growth and earnings in a volatile market environment with 9% organic sales growth in 2022. This...
BioCorRx Appoints Pharmaceutical & Finance Veteran Harsha Murthy to the Board of Directors
ANAHEIM, CA, Jan. 24, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative...
Dyadic Announces Initiation of Dosing of First-In-Human Phase 1 Trial to Demonstrate Clinical Safety and Antibody Response in Humans for DYAI-100 COVID-19 Recombinant Protein RBD Booster Vaccine Candidate
JUPITER, Fla., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI),...
Male Plus Naturally Combats the Effects of Alcohol on the Libido
Alcohol and Excessive Drinking Are Well-Known for Their Ability to Dampen Sexual Appetite. Male Plus Offers a Natural Solution.FORT LAUDERDALE,...
Male Plus Taps Into the Intimate Power of Tribulus Terrestris
The Natural Libido Enhancer’s Formula Includes a Potent Dose of the Ancient, Venerable, and World-Renowned HerbFort Lauderdale, FL, Jan. 23,...
Procaps Announces Key Changes to the Board of Directors
International Corporate Executive and Attorney Alberto Eguiguren Correa Appointed to Board of Directors MIAMI and BARRANQUILLA, Colombia, Jan. 19, 2023...
Dyadic Announces Sale of Equity Interest in Alphazyme
JUPITER, Fla., Jan. 19, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic", or the "Company") (NASDAQ: DYAI), a global biotechnology...
BioCorRx Announces Completion of Treatment Phase of Study Subjects and Preliminary Safety Data from Phase I Clinical Trial of BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder
ANAHEIM, CA, Jan. 19, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and...
Evoke Pharma Announces Acceptance of an Abstract at the Academy of Managed Care Pharmacy (AMCP) Annual Meeting 2023
Real-world study compares diabetic gastroparesis patient utilization of healthcare resources before and after initiation of GIMOTISOLANA BEACH, Calif., Jan. 18,...
BioSenic appoints Dr Carole Nicco as Chief Scientific Officer
Dr Nicco will oversee the development of pipeline across BioSenic’s cell therapy and autoimmune disease platform and will be responsible...
PetMeds® to Acquire PetCareRx
The Acquisition Is Expected to Accelerate Revenue Growth and Expand Addressable Market in a $120 Billion* U.S. IndustryDELRAY BEACH, Fla.,...
Smart for Life CEO Issues Year-End Letter to Shareholders
2022 Marked Transformative Year for Smart for Life; Built a Solid Foundation Through Acquisitions and Anticipates Significant Growth in 2023MIAMI,...